PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
149 hedge funds and large institutions have $491M invested in Progenics Pharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 32 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
-6
Holders Change %
-3.87%
% of All Funds
3.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
64
Reduced
32
Closed
26
Calls
$7.33M
Puts
$8.83M
Net Calls
-$1.51M
Net Calls Change
-$10.3M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$38.6M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$19M |
| 3 |
State Street
Boston,
Massachusetts
|
$41.1M |
| 4 |
BlackRock
New York
|
$83.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$10.3M |
